🇺🇸 FDA
Patent

US 9757379

Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)

granted A61KA61K31/136A61K31/4184

Quick answer

US patent 9757379 (Inhibition of HIF-2α heterodimerization with HIF1β (ARNT)) held by The Board of Regents of the University of Texas System expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/136, A61K31/4184, A61K31/4192, A61K31/4245